Compare ANIP & TNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | TNC |
|---|---|---|
| Founded | 2001 | 1870 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 1999 | 1994 |
| Metric | ANIP | TNC |
|---|---|---|
| Price | $85.19 | $85.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $110.00 | $79.00 |
| AVG Volume (30 Days) | ★ 291.4K | 155.4K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 1.53% |
| EPS Growth | ★ 419.23 | N/A |
| EPS | ★ 1.28 | 0.01 |
| Revenue | $206,547,000.00 | ★ $1,137,600,000.00 |
| Revenue This Year | $21.01 | $5.77 |
| Revenue Next Year | $17.59 | $4.95 |
| P/E Ratio | ★ $66.23 | $8,560.00 |
| Revenue Growth | ★ 2.47 | N/A |
| 52 Week Low | $62.61 | $60.18 |
| 52 Week High | $99.50 | $91.93 |
| Indicator | ANIP | TNC |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 45.86 |
| Support Level | $77.16 | $79.08 |
| Resistance Level | $87.42 | $88.53 |
| Average True Range (ATR) | 2.60 | 2.50 |
| MACD | 0.28 | -0.53 |
| Stochastic Oscillator | 75.84 | 18.68 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.